Interius BioTherapeutics
$350.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Interius BioTherapeutics is currently valued at $350.0M as of August 21, 2025. The company has raised a total of $169.6M in funding.
Capital Efficiency
With a capital efficiency ratio of 2.06x, Interius BioTherapeutics has achieved a valuation that is 2.06 times the total capital raised. This metric indicates moderate capital efficiency.
Investment Perspective
Interius BioTherapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Interius BioTherapeutics Worth in 2025?
As of 2025, Interius BioTherapeutics is valued at $350.0M, based on the company's Merger/Acquisition funding round in August 21, 2025. This valuation positions Interius BioTherapeutics as one of the leading private companies in the sector.
Interius BioTherapeutics Valuation History
Interius BioTherapeutics's funding history demonstrates steady growth and investor confidence.
How Interius BioTherapeutics Valuation is Determined
Private company valuations like Interius BioTherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Interius BioTherapeutics Valuation FAQs
Is Interius BioTherapeutics profitable?
Interius BioTherapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Interius BioTherapeutics's valuation compare to competitors?
Interius BioTherapeutics is valued at $350.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Interius BioTherapeutics IPO?
Interius BioTherapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Interius BioTherapeutics shares through secondary market platforms.